The virus platform has proven its innovative potential in developing infection models using organoids. It significantly accelerated the development of antiviral drugs and enabled precise drug evaluation in a human-like environment, which was highly impressive. Avion Research Institute achieved excellent results in efficacy validation during the drug development process using this platform.